Skip to content

AC Clinico Belgium

Active Private limited companyfounded 2001active for 25 yearsKleine Kloosterstraat 6, 1932 ZaventemKBO/BCE: BE 0475.329.890 subsidiary of Mars, Incorporated#1 employer in Belgium, Veterinary activities sector

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2001
peak €1.6m (2022)
-not published
lowest -€6,973 (2024)
€1.7m▲ €1.8m
peak €28.0m (2025)
€28.0m▲ 17.2%
€5.7m▼ 55.6%
peak 181.7 FTE (2024)
153.4 FTE▼ 15.6%
Board12 names since 2020
7 directorsPeter Verdyck and 6 others
Owners
consolidatesMars, Incorporated
Documentsfilings and deeds
03-07-202628 days before the deadline
2025financial year
Back to profit: €1.7mStaff from 181.7 FTE to 153.4 FTECapital contribution of €2,359,841.72 11-03Equity from €23.9m to €28.0mDebts from €12.9m to €5.7mCash from €263,276 to €403,148

Key points

from the 2025 annual accounts

Result

€1.7m €1.7m
-€6,9702024€1.7m2025

Back in profit in 2025, after a loss of €6,973 in 2024.

Staff

176 employees on 31-12-2025
2221202124242022232020231361392025

In 2025, 136 people joined and 139 left. On top of that, 0.3 agency workers worked there on average.

Payment terms

63 days to suppliers
Suppliers
68 to 63
Customers
75 to 53

AC Clinico Belgium pays its suppliers 5 days earlier than in 2024. Customers pay 22 days earlier.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

Three of the last ten came late. The 2024 accounts came latest: 57 days after the end of the period.

Board

4 joined · 4 left

Board changed. Latest change 03-06-2026 · 4 in office.

Checked score

92
Excellent
Financially stronger than 73% of all companies
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.2% across 3 companies (NACE 75, medium-sized).

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.3%▲ +0.1 percentage points vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.5%▲ +0.2 percentage points vs 07-2025 09-2025: 0.7%▲ +0.2 percentage points vs 08-2025 10-2025: 1.3%▲ +0.6 percentage points vs 09-2025highest value 11-2025: 0.5%▼ -0.8 percentage points vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.5%● unchanged vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.4%▼ -0.1 percentage points vs 04-2026 06-2026: 0.5%▲ +0.1 percentage points vs 05-2026 07-2026: 0.4%▼ -0.1 percentage points vs 06-2026 08-2026: 0.2%▼ -0.2 percentage points vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value 11-2026: 0.2%● unchanged vs 10-2026lowest value

Financial strength
Strong

100+10equity 83.0% of total assets
47+6short-term debt 16.6% · cash 1.2%
80+9return on assets 5.2%

Score breakdown

raises risk
1 change of registered office in 24 months
Liquidity: current ratio 3.17, cash €403,148
1 of the last 3 accounts late
lowers risk
Sector: Veterinary activities (NACE 75)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (all companies). It does better than 93% of them on solvency, 55% on liquidity, 82% on profitability and 62% on growth.

The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 1,579 companies had the same profile as AC Clinico Belgium has now. Each dot stands for 4 companies, two years later.

96.6%
were still trading
3.2%
stopped another way
0.1%
went bankrupt
  • Medium-sized
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of AC Clinico Belgium itself: 0.2% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,579 companies, not a prediction for AC Clinico Belgium. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €2,400,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 3.17 (2.24 in 2024), above the usual 1.5. Short-term debt is 16.6% and cash 1.2% of total assets. 17% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Liquidity: current ratio 3.17, cash €403,148
NBB · annual accounts
raises risk · 1 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Veterinary activities (NACE 75)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
28 days early
2024
57 days late
2023
1 day late
2022
18 days early
2021
80 days early
2020
88 days early
2019
77 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 33 days before the deadline. In the sector (NACE 75), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (4 of the last 5 accounts filed within 62 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

VM
Director, since 07-10-2024
ML
Director, since 24-12-2025
SI
Director, since 24-12-2025
RR
Director
PB
Auditor, Bart Van Gompel

Shares in 1 company, AC VetoCambre

Board & ownership

Recent changes

New establishment in Zaventem AniCura Dierenartsencentrum Saventa Zaventem, Kleine Kloosterstraat 8
Appointment: Robert Reijers (director) General meeting of 03-06-2026 · Gazette deed
3 directors appointed, 5 resignations Resignations: Bob Carrière, Maximiliaan Reijers, Fabrice Ribourg, Monica Vos and Peter Verdyck · Appointments: Sam Ivens, Monica Vos and Mattea Lenhoff · General meeting of 24-12-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0475329890
All 72 events

Comparable companies

same main activity, similar in size and age
Company
AC Clinico Belgium Zaventem €24.4m 9.6% 83.0% 153.4
CER-Groupe Marche-en-Famenne €22.4m 3.8% 66.6% 150.6
ASSOCIATION REGIONALE DE SANTE ET D'IDENTIFICATION ANIMALES - REGIONALE VEREINGUNG DER TIERGESUNDHEIT UND - IDENTIFIZIERUNG Ciney €11.0m 7.3% 77.8% 136.9
DIERENGEZONDHEIDSZORG VLAANDEREN Lier €23.0m 10.6% 74.9% 128
Antech Diagnostics Belgium Namur €11.1m -28.0% 95.6% 33.5
EQUITOM Lummen €13.7m -3.5% 19.7% 44.7
PEETERS Philippe Saint-Ghislain - - 20.8% -
-10%0%10%20%€10,000€100,000€1m€10mAC Clinico BelgiumEBIT margin

Grey: the largest companies of the sector (veterinary activities (NACE 75)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as AC Clinico Belgium: veterinary services (NACE 75000). They are comparable in size and age: total assets between €4.7m and €44m, founded between 1961 and 2009.

Official details

Source: KBO
Status
Active since 17-07-2001Normal situation
Activity
Veterinary servicesNACE 75000
Joint committee
336Liberal professions · annual accounts 2025
Establishment units
2.198.372.4652235 Hulshout, since 19-01-1990
2.228.050.8044800 Verviers, since 11-09-1992and 24 others
Financial year end
31 December
Peppol
Reachable since 16-12-2025
Company details

Annual accounts 2025

€33.7m▼ 8.5%
Employeeson 31-12-2025
176
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on AC Clinico Belgium

Solvency rose in 2025 from 64.8% to 83.0% because of the retained profit and lower debts.

In January 2026, four directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about AC Clinico Belgium

What is the company number of AC Clinico Belgium?
The company number of AC Clinico Belgium is 0475.329.890. The VAT number is the same number with BE in front: BE 0475.329.890.
Where is AC Clinico Belgium based?
The registered office is at Kleine Kloosterstraat 6, 1932 Zaventem.Company details
What does AC Clinico Belgium do?
According to the KBO register, the main activity is veterinary services (NACE 75000).
What is the legal form of AC Clinico Belgium?
AC Clinico Belgium is a private limited company (BV).
When was AC Clinico Belgium founded?
AC Clinico Belgium was founded on 17-07-2001.
Is AC Clinico Belgium still active?
Yes, AC Clinico Belgium is an active enterprise in the KBO register.
How many employees does AC Clinico Belgium have?
AC Clinico Belgium had an average of 153.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does AC Clinico Belgium fall under?
In its 2025 annual accounts, AC Clinico Belgium states joint committee 336 (Liberal professions).
What is the turnover of AC Clinico Belgium?
The turnover of AC Clinico Belgium was €24.4m in financial year 2025, according to the filed annual accounts.
Is AC Clinico Belgium profitable?
In financial year 2025, AC Clinico Belgium made a profit of €1.7m.
Where can I find the annual accounts of AC Clinico Belgium?
AC Clinico Belgium filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AC Clinico Belgium due?
AC Clinico Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.